F-18 FDG PET/CT in rectal carcinoma: where are we now?
- PMID: 21892038
- DOI: 10.1097/RLU.0b013e318219b507
F-18 FDG PET/CT in rectal carcinoma: where are we now?
Abstract
This short review aims at summarizing the available data pertaining to the usefulness of F-18 FDG PET/CT in rectal cancer. It is specifically focused on the emerging role of F-18 FDG PET/CT in assessing the response to neoadjuvant combined radiochemotherapy in locally advanced rectal cancer. It also probes the possibility of finding standardized PET/CT parameters that are capable of differentiating responders from nonresponders in whom therapeutic approach could be modified.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
